Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator.

  title={Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator.},
  author={Michael L. Rohan and Aimee M. Parow and Andrew L. Stoll and Christina M. Demopulos and S.D. Friedman and Stephen R Dager and John Hennen and Bruce M Cohen and Perry F. Renshaw},
  journal={The American journal of psychiatry},
  volume={161 1},
OBJECTIVE Anecdotal reports have suggested mood improvement in patients with bipolar disorder immediately after they underwent an echo-planar magnetic resonance spectroscopic imaging (EP-MRSI) procedure that can be performed within clinical MR system limits. This study evaluated possible mood improvement associated with this procedure. METHOD The mood states of subjects in an ongoing EP-MRSI study of bipolar disorder were assessed by using the Brief Affect Scale, a structured mood rating… 

Figures and Tables from this paper

Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression
Antidepressant effects of magnetic resonance imaging—based stimulation on major depressive disorder: a double-blind randomized clinical trial
The antidepressant effects of DWI and T1 MRI protocols were demonstrated and may point to usefulness of MR stimulation for clinical use in patients with major depressive disorder.
A Double-Blind Pilot Dosing Study of Low Field Magnetic Stimulation (LFMS) for Treatment-Resistant Depression (TRD)
Three 20-min LFMS sessions were required for active LFMS to have a mood-enhancing effect for individuals with treatment-resistant depression, and this effect may be transient.
Deep-brain magnetic stimulation as add-on treatment to lithium carbonate in the treatment of bipolar depression: study protocol for a randomized, double-blind, sham-controlled trial
The trial will verify the effectiveness of deep-brain magnetic stimulation with lithium carbonate in the treatment of bipolar disorder, providing evidence as to whether this combined therapy has the potential to be new alternative treatment for bipolar disorder.
Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor
Rhythmic LFMS was effective for MDD and BDNF may moderate the efficacy of LFMS, and HAMD–17, HAMA, and CGI–S scores were significantly reduced with both RAS and RDS.
Can Magnets Make Us Happy? Investigating the Role of Dopamine in Putative Antidepressant Low-Intensity Magnetic Stimulation
The antidepressant effect found in previous studies could be partially reproduced and has been observed to increase with stimulation frequency, but no evidence of dopamine as a mediating factor has been found and an involvement of the noradrenergic network instead seems more probable.


Transcranial magnetic stimulation for depression and other psychiatric disorders
Repetitive transcranial magnetic stimulation has demonstrable beneficial effects in depression and there now needs to be randomized controlled trials to compare rTMS directly with standardized electroconvulsive therapy in order to take this subject forward.
A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression.
Repetitive transcranial magnetic stimulation (rTMS) is an emerging potential treatment for depression, but the data supporting its efficacy have not been systematically reviewed. The purpose of this
Transcranial magnetic stimulation for treating depression.
It is suggested that there is no strong evidence for benefit from using transcranial magnetic stimulation to treat depression, although the small sample sizes do not exclude the possibility of benefit.
A controlled trial of daily left prefrontal cortex TMS for treating depression
Preliminary evidence for a beneficial effect of low‐frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia
Preliminary results suggest that low‐frequency rTMS may be beneficial mainly in MD and to some extent in schizophrenia, and support the need for controlled studies to further validate its therapeutic potential.